Tetrapeptide-3 (CAS: 827306-97-8) Anti-Wrinkle Peptide

PRODUCT PARAMETERS

Tetrapeptide-3

CAS: 827306-97-8

Anti-Wrinkle/Anti-Aging/ Barrier Repair/Soothing and Anti-Inflammatory/Sensitive Skin Care

Tetrapeptide-3: bioactive peptide (KGHK-NH₂, CAS 827306-97-8). Reduces IL-8 inflammation, stimulates ECM, repairs skin barrier. Anti-aging.

Description
About Us
Request A Quote

Description

Tetrapeptide-3 Basic Information

Tetrapeptide-3 Powder Specification

Tetrapeptide-3 Solution Specification

The mechanism of Tetrapeptide‑3

Advantage and Benefit

FAQs

A: Tetrapeptide-3 stimulates the production of laminin-5, fibronectin, and collagen VII—key structural proteins at the dermal-epidermal junction (DEJ). By strengthening the DEJ, it anchors the epidermis more firmly to the dermis, reduces fine lines and wrinkles, and improves overall skin firmness and resilience (source: Creative-Peptides; AusHealthIngredients).

A: Tetrapeptide-3 contains the bioactive sequence KGHK, which is naturally released from the extracellular matrix protein SPARC during vascular remodeling. This tetrapeptide stimulates angiogenesis, regulates endothelial cell proliferation, and promotes tissue repair. By mimicking this natural signaling pathway, Tetrapeptide-3 helps restore microvascular support and dermal-epidermal communication, contributing to overall skin regeneration and resilience (source: Lane et al., J Cell Biol, 1994, PMC2120067; GLPBIO).

A: Shiseido discovered that pericytes from dermal capillaries can migrate to the epidermis and transform into epidermal stem-like cells, promoting regeneration. Aging increases epidermal-derived Netrin-1, repelling capillaries and reducing pericyte migration. Tetrapeptide-3’s KGHK sequence—derived from SPARC during vascular remodeling—supports angiogenesis and microvascular health, conceptually complementing this capillary–epidermis axis. Together, they suggest a unified strategy: maintaining capillary function and ECM signaling to sustain epidermal stem cell supply and skin renewal (source: Shiseido News Release, 2022; Lane et al., J Cell Biol, 1994).

GENOPEP GROUP | The Engine of Your Peptide Innovation

GENOPEP Group is a leading global peptide technology solutions provider, specializing in R&D, manufacturing, and commercialization in the fields of skin science and biopharmaceuticals. Supported by advanced scientific capabilities and a fully integrated supply chain, we deliver efficient and reliable innovation support to skincare brands worldwide.

We focus on three key service areas, empowering partners throughout the entire product lifecycle from concept to market:

  • Active Ingredients and Formulation Development – Grounded in cutting-edge research, we provide high-efficacy skincare ingredients, ingredient complexes, and complete formulation solutions.
  • End-to-End Production Support – Covering the full journey from lab-scale R&D and pilot optimization to commercial manufacturing, ensuring consistent product quality and reliable supply.
  • Custom Synthesis Services – With strong capabilities in novel molecule development, we specialize in the design, synthesis, and preparation of peptide-based novel ingredients and related reference standards.

We believe in technology-driven products and collaboration-driven value. GENOPEP is not just a supplier—we are your trusted innovation partner, dedicated to co-creating the next generation of skincare solutions with you.

REQUEST A QUOTE

REQUEST A QUOTE